Atai Life Sciences N.V.
NASDAQ:ATAI
1.08 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 45.034 | 190.613 | 362.266 | 97.246 | 30.062 |
| Short Term Investments
| 109.223 | 82.496 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 154.257 | 273.109 | 362.266 | 97.246 | 30.062 |
| Net Receivables
| 2.257 | 5.631 | 0.913 | 1.291 | 8.704 |
| Inventory
| 0 | -5.631 | 0 | 0.457 | 0.173 |
| Other Current Assets
| 29.078 | 14.036 | 11.903 | 0.554 | 0.207 |
| Total Current Assets
| 185.592 | 287.145 | 375.082 | 99.548 | 39.146 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 2.204 | 0.928 | 0.149 | 0.071 | 0.021 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 102.962 | 6.755 | 27.759 | 8.044 | 22.949 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.72 | 10.613 | 11.176 | 3.885 | -22.97 |
| Total Non-Current Assets
| 107.886 | 18.296 | 39.084 | 12 | 22.97 |
| Total Assets
| 293.478 | 305.441 | 414.166 | 111.548 | 62.116 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 4.589 | 2.399 | 6.004 | 3.083 | 0.688 |
| Short Term Debt
| 0.275 | 0.18 | 0 | 0 | 0 |
| Tax Payables
| 0.715 | 2.224 | 8.137 | 0.997 | 0.123 |
| Deferred Revenue
| 0.715 | -0.18 | 0 | 0 | 0 |
| Other Current Liabilities
| 14.541 | 17.498 | 14.931 | 9.215 | 0.919 |
| Total Current Liabilities
| 20.12 | 19.897 | 20.935 | 12.298 | 1.607 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 15.211 | 15.117 | 0.743 | 2.177 | 0.157 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 13.831 | 265.401 | 383.437 | 1.705 | 0.714 |
| Total Non-Current Liabilities
| 29.042 | 280.518 | 384.18 | 3.882 | 0.871 |
| Total Liabilities
| 49.162 | 300.415 | 405.115 | 16.18 | 2.478 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 18.573 | 18.562 | 18.002 | 13.372 | 10.51 |
| Retained Earnings
| -550.938 | -510.188 | -357.803 | -189.995 | -20.152 |
| Accumulated Other Comprehensive Income/Loss
| -19.46 | -21.702 | -8.336 | 5.819 | -1.426 |
| Other Total Stockholders Equity
| 794.787 | 774.068 | 348.137 | 261.626 | 69.819 |
| Total Shareholders Equity
| 242.962 | 260.74 | -348.137 | 90.822 | 58.751 |
| Total Equity
| 244.316 | 265.766 | -339.086 | 95.368 | 59.638 |
| Total Liabilities & Shareholders Equity
| 293.478 | 305.441 | 414.166 | 111.548 | 62.116 |